Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 4 de 4
Filtrar
1.
J Cancer Educ ; 38(1): 378-382, 2023 02.
Artículo en Inglés | MEDLINE | ID: mdl-35838882

RESUMEN

Despite an estimated population of over 201 million and over 115,950 yearly diagnosed new cases of cancer, Nigeria does not have dedicated medical oncologists. Most oncology care is delivered through surgical and clinical oncologists, who are trained in both radiation and medical oncology and they number fewer than 50 in the country. With a limited number of oncology professionals, cancer patients in Nigeria experience poor health outcomes, with an estimated cancer mortality rate of 75,000 deaths per year. Participants from 15 Nigerian states were selected to attend the medical oncology training. Through the support of Fulbright Specialist Program and Project PINK BLUE, two of the authors delivered 10 days of lectures based on ASCO, ESMO, and NCCN guidelines. Mean scores of both the pre- and post-course tests as well as a 1-year follow-up test were compared using GraphPad Prism 7.0a by paired t-tests. Forty-four clinical oncologists were selected for participation. Twenty-five (57%) completed the pre- and post-course tests. Of the 25 that completed both tests, percentage of correct answers increased from 45 to 59% (2-sided p-value < 0.0001). Improvements were seen in attending doctors 45 to 59% (p = 0.0046) and resident doctors 45 to 59% (0.0007). Eleven doctors responded to the 1-year follow-up test. Although not statistically significant, a numerical pattern for the benefits was maintained 1 year after the program (45% pre-course versus 52% post-course correct answers, Fisher's exact, p = 0.4185). In the short term, the training improved medical oncology knowledge in Nigeria, regardless of the participant's carrier stage. Long-term benefits were not sustained in a small sample of participants, and continuing education strategies are necessary. Similar models may be employed across Africa.


Asunto(s)
Neoplasias , Médicos , Humanos , Nigeria , Neoplasias/tratamiento farmacológico , Oncología Médica , Personal de Salud/educación
2.
West Afr J Med ; 13(1): 17-9, 1994.
Artículo en Inglés | MEDLINE | ID: mdl-8080824

RESUMEN

The unsatisfactory high rate of recurrence following the traditional approach for the radiotherapy of keloid scars in Nigeria, led to the design of this study which employed a short course post operative radiotherapy regime. Two hundred and forty four patients with four hundred and fifty four (454) keloidal scars treated with superficial X-ray therapy within 72 hours following surgical excision at the Lagos University Teaching Hospital Lagos, Nigeria, between January, 1984 and December, 1988 were analyzed. The commonest site treated was the ear lobe (36.8%). Radiation dose ranged between 5-6Gy in single sessions and 12-15Gy in 3 fractions over 5 days. A complete response rate of 93% at 24 months was achieved. The treatment was well tolerated with no serious complications reported to date.


Asunto(s)
Queloide/radioterapia , Cuidados Posoperatorios/métodos , Terapia Combinada , Estudios de Seguimiento , Humanos , Queloide/epidemiología , Nigeria/epidemiología , Dosificación Radioterapéutica , Recurrencia , Resultado del Tratamiento
3.
Afr J Med Med Sci ; 22(3): 65-8, 1993 Sep.
Artículo en Inglés | MEDLINE | ID: mdl-7839915

RESUMEN

Four hundred and five (405) patients with histologically proven primary breast carcinoma were analysed in this study. There was complete response of 64.2% after surgery and radiotherapy. This is a better result in comparison with developing countries, for example, Nigeria where over 90% of cancer patients report at a late stage before treatment and inadequate radiotherapy facilities lead to long waiting list. A tumour regression rate (complete and partial) of 98.3% was obtained. This work has shown that most women with breast cancer could be cured when the lesions are detected very early and sizes smaller.


Asunto(s)
Neoplasias de la Mama/patología , Neoplasias de la Mama/terapia , Adulto , Anciano , Anciano de 80 o más Años , Neoplasias de la Mama/mortalidad , Terapia Combinada , Femenino , Humanos , Persona de Mediana Edad , Estadificación de Neoplasias , Pronóstico , Inducción de Remisión , Estudios Retrospectivos , Tasa de Supervivencia , Resultado del Tratamiento
4.
Nig Q J Hosp Med ; 21(2): 145-8, 2011.
Artículo en Inglés | MEDLINE | ID: mdl-21913513

RESUMEN

BACKGROUND: The Radiotherapy and Oncology Centre at Ahmadu Bello University Teaching Hospital, Zaria, Nigeria, commenced services with technical cooperation support from the International Atomic Energy Agency, Vienna, Austria in 1995. Brachytherapy services used to be offered at the ABUTH, Tudun-Wada, Zaria since 1995. Teletherapy and other Oncological services commenced at its Permanent Site, Shika- Zariaon Monday July, 2000. OBJECTIVE/METHODS: This is an incidental report of radiation over and under dose of 331 patients treated with Cobalt-60 machine (CIRUS) from July, 2000-December, 2002. RESULTS: 105 (31.7%) of the patients received 10-20% higher doses than prescribed, 161 (48.6%) received about the prescribed dose while 65 (19.7%) of the patients received under dose. CONCLUSION: The purpose of the report is to highlight that incidents and accidents can occur with the radiotherapy equipment at any centre despite trained staff operating the equipment. Any incident or accident should be reported to the appropriate national and international atomic energy agencies.


Asunto(s)
Braquiterapia/normas , Falla de Equipo , Dosis de Radiación , Adulto , Braquiterapia/instrumentación , Hospitales de Enseñanza , Humanos , Hallazgos Incidentales , Persona de Mediana Edad , Nigeria , Garantía de la Calidad de Atención de Salud , Traumatismos por Radiación , Oncología por Radiación/normas , Dosimetría Termoluminiscente/métodos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA